Grant: Discovery Grants Program - Individual
McMaster University
$29,000.00
Pharmaceutical Based Granulation by Extrusion
EF 2013-14
Résumé
Granulation involves the agglomeration of powdered solids for the purpose of easy flow inside a manufacturing plant, protection of workers from hazardous dust, and the improvement of end properties of products formed with these materials. In the high-tech pharmaceutical market, granulation is a necessary step in the production to tablets - the most popular dosage form of drugs for Canadians and world-wide. This research proposal is intent on studying a new innovative extruder technology being developed in the pharmaceutical field to granulate powdered solids on a continuous basis. Extrusion is being found to offer a substantial step forward in granulation for the industry since it can give a level of consistency, environmental control and product quality not possible by traditional processes. Extrusion is also the only technology besides fluidized beds which is capable of providing the necessary level of flexibility in production operation that matches the future vision of pharmaceutical manufacturing in regards to single pieces of equipment being used as multiple product manufacturing platforms (AAPS News Magazine, Aug 11, 2001 pp 16-20). Being a new technology there are no fundamental studies on the mechanism of granulation within the extruder nor is there any guidance to be given to industrial users on process troubleshooting, equipment scale-up, or design. The research program of this Discovery grant intends to address this lack of knowledge. The goals of the program are to model the micromechanics of granulation based on different binder types, design new screw elements to increase robustness, and to develop tools to aid Canada's industry in building up more manufacturing capacity by this approach. The area of research is highly attractive to HQP in Chemical Engineering as the industry (particularly, pharmaceutical) is shifting its needs to new hires with greater manufacturing knowledge in continuous technologies. The research program will give HQP the opportunity to become skilled in all aspect of extrusion operation, drug preparation, and product characterization related to powder granulation.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
249687-2012
Name nom
Thompson, Michael
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
2
Nb partie
5
Application title
Pharmaceutical Based Granulation by Extrusion
Keyword
NSERC
Application summary
Granulation involves the agglomeration of powdered solids for the purpose of easy flow inside a manufacturing plant, protection of workers from hazardous dust, and the improvement of end properties of products formed with these materials. In the high-tech pharmaceutical market, granulation is a necessary step in the production to tablets - the most popular dosage form of drugs for Canadians and world-wide. This research proposal is intent on studying a new innovative extruder technology being developed in the pharmaceutical field to granulate powdered solids on a continuous basis. Extrusion is being found to offer a substantial step forward in granulation for the industry since it can give a level of consistency, environmental control and product quality not possible by traditional processes. Extrusion is also the only technology besides fluidized beds which is capable of providing the necessary level of flexibility in production operation that matches the future vision of pharmaceutical manufacturing in regards to single pieces of equipment being used as multiple product manufacturing platforms (AAPS News Magazine, Aug 11, 2001 pp 16-20). Being a new technology there are no fundamental studies on the mechanism of granulation within the extruder nor is there any guidance to be given to industrial users on process troubleshooting, equipment scale-up, or design. The research program of this Discovery grant intends to address this lack of knowledge. The goals of the program are to model the micromechanics of granulation based on different binder types, design new screw elements to increase robustness, and to develop tools to aid Canada's industry in building up more manufacturing capacity by this approach. The area of research is highly attractive to HQP in Chemical Engineering as the industry (particularly, pharmaceutical) is shifting its needs to new hires with greater manufacturing knowledge in continuous technologies. The research program will give HQP the opportunity to become skilled in all aspect of extrusion operation, drug preparation, and product characterization related to powder granulation.